Please ensure Javascript is enabled for purposes of website accessibility

Maryland to receive $15.5M from Glaxo over drug ads (access required)

Maryland has recovered $15 million from drug maker GlaxoSmithKline LLC to resolve allegations that the company engaged in improper marketing of the prescription drugs Avandia, Avandamet and Avandaryl, all of which are used to treat diabetes.